1. Home
  2. AERT vs CRIS Comparison

AERT vs CRIS Comparison

Compare AERT & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aeries Technology Inc.

AERT

Aeries Technology Inc.

N/A

Current Price

$0.59

Market Cap

27.9M

ML Signal

N/A

Logo Curis Inc.

CRIS

Curis Inc.

N/A

Current Price

$1.19

Market Cap

14.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AERT
CRIS
Founded
2012
2000
Country
Singapore
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
27.9M
14.6M
IPO Year
N/A
2000

Fundamental Metrics

Financial Performance
Metric
AERT
CRIS
Price
$0.59
$1.19
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$16.50
AVG Volume (30 Days)
171.2K
116.3K
Earning Date
11-10-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$69,346,000.00
$11,650,000.00
Revenue This Year
N/A
$6.13
Revenue Next Year
N/A
$8.44
P/E Ratio
N/A
N/A
Revenue Growth
N/A
13.56
52 Week Low
$0.46
$1.02
52 Week High
$2.67
$4.50

Technical Indicators

Market Signals
Indicator
AERT
CRIS
Relative Strength Index (RSI) 46.82 40.69
Support Level $0.54 $1.14
Resistance Level $0.59 $1.41
Average True Range (ATR) 0.06 0.11
MACD 0.00 -0.00
Stochastic Oscillator 45.84 8.78

Price Performance

Historical Comparison
AERT
CRIS

About AERT Aeries Technology Inc.

Aeries Technology Inc is a professional and management services partner offering a range of management consultancy services for private equity sponsors and their portfolio companies with engagement models that are designed to provide a mix of deep vertical specialty, functional expertise, and digital systems and solutions to scale, optimize and transform a client's business operations. It supports and drives its client's growth across the globe by providing a range of management consultancy services involving professional advisory services and operations management services to build and manage dedicated delivery centers in appropriate locations based on customer business needs.

About CRIS Curis Inc.

Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.

Share on Social Networks: